Objective: To fi nd out the risk factors for developing Hepatic Encephalopathy in patients suffering from Chronic liver disease. Background: Hepatic encephalopathy (HE) is a neuropsychiatric disorder that is caused by liver damage. In its pathology, alterations in normal brain function are associated with an increase in blood ammonia, benzodiazepine like substances, products of neurotoxic fatty acids, and other gut derived toxins, which gain access to the brain as a result of liver dysfunction. Study Design: Hospital based descriptive, cross sectional study. Settings: Medical Unit 1, Ward-5, Jinnah Post Graduate Medical Centre, Karachi. Duration: July 2013 to December 2013. Patients and Methods: About 150 patients admitted in medical unit 1 with a diagnosis of chronic liver disease in a state of hepatic encephalopathy were included in this study. Patients suffering from viral or bacterial encephalitis, stroke, brain tumor, Wernicke's encephalopathy were excluded from the study. Results and Observations: There were 96 (64%) female and 54 (36%) were male patients. Mean age of the patients was 52.45 (±12.271) years. 80 (53.33%) patients were having constipation. Infection was found in 55 (36.66%) cases. Upper GI Bleed was present in 51 (34%) patients. 44 (29.33%) patients had moderate to severe electrolyte imbalance as the cause. Constipation alone was the cause in 11.33% of cases. More than one factor was found to be responsible in around 56% of patients while in 6.6% of cases none of these precipitating factors was isolated. Conclusion: Constipation is the commonest cause of hepatic encephalopathy followed by infection, upper GI bleed and electrolyte imbalance.
INTRODUCTION
Chronic liver disease is a worldwide major problem and alcohol is the leading cause of chronic liver disease in western societies, while hepatitis B and C viruses are the major in Pakistan. The prevalence of hepatitis B is over 10% in the Asia-pacifi c region where as the prevalence of chronic hepatitis C in the Asia-pacifi c region is variable between 4 to 12%. 1, 2 It causes signifi cant morbidity and mortality, mainly due to complications like hepatic encephalopathy, ascites, hepatorenal syndrome (HRS) and esophageal variceal hemorrhage (EVH). 3 Hepatic encephalopathy (HE) is present in up to 70% of all patients with cirrhosis, including patients with abnormalities demonstrable only by psychometric testing, 4, 5 out of which about 30% patients of chronic liver disease die of hepatic encephalopathy. 6, 7 Hepatic encephalopathy describes a range of neuropsychiatric oddities that occur as a result of liver failure. The most primitive known paper to date on HE is by Giovanni Battista Morgagni in eighteenth century. Morgagni's book of medicine reported the case of a man with liver cirrhosis who had coma and subsequently died, whose gross brain examination did not show any alteration (Morgagni 1765). 8 Many ideas generated and struggles are made to fi nd out the exact pathophysiology of H.E. The diversion of portal blood into the systemic circulation through Porto systemic collateral vessels is found to be an imperative requirement Hepatic encephalopathy in chronic liver disease; predisposing factors in a developing country for the syndrome. It accompanies portal-systemic shunting of venous blood that occurs either spontaneously, due to cirrhosis, or non-cirrhotic portal hypertension, or surgically following porto-caval anastomosis surgery or trans-jugular intra-hepatic porto-systemic shunt (TIPS) aimed at relieving portal hypertension. 9 A relationship between portal-systemic shunting of blood and behavioral alterations, including coma, was clearly proven in porto-caval shunted dogs (i.e., submitted to Eck fi stula) by Hahn et al. (1893) 10 who demonstrated that meat-rich meals could cause 'encephalitis'.
Many studies also emphasize the role of neurotoxic agents in H.E. Van Caulet in 1932 11 declared that Ammonia is the principal neurotoxin in instigating coma and disturbed brain function in patients of cirrhosis, the same was then proven by Sthal in 1936. 12 Although many critic focused strictly on the involvement of neurotoxins and it remained controversial for a long period of time but now it is widely accepted that they have a certain role in the pathogenesis of H.E and among them ammonia is the toxin of interest. Ammonia formed by the colonic bacteria is carried to the liver via portal vein after absorption, where it is incorporated in the urea cycle for detoxifi cation. Other gut-derived toxins have also been proposed e.g. benzodiazepine like substances, products of colonic bacterial metabolism such as neurotoxic short and medium chain fatty acids, phenols and mercaptans and manganese. Ammonia and the other substances gain access to the systemic circulation as a result of decreased hepatic function or porto-systemic shunts and harmfully disturbs brain function and theaters a role in the pathogenesis of H. E. In the brain these compounds produce alterations of neurotransmission that affect cognizance and behavior. Abnormalities in glutamatergic, serotoninergic, gaminobutyric acid-ergic (GABA-ergic) and catecholamine pathways have been described in experimental hepatic encephalopathy. The role of ammonia in hepatic encephalopathy is supported by the fi nding of high arterial ammonia level. The permeability of blood-brain barrier for ammonia is increased in patients with hepatic encephalopathy. Furthermore, ammonia after entering into the astrocytes, is metabolized and leads to changes in neurotransmission and hence alters the cellular functions. Manganese is deposited in basal ganglia and induces extra pyramidal symptomatology. It's also been proposed that an alteration in the ratio of branch chain amino acids and aliphatic amino acids can also predisposes to hepatic encephalopathy.
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PATIENTS AND PROCEDURES
Study design and setting
It was a hospital based descriptive, cross sectional study, carried out at department of medicine, ward 5, Jinnah Postgraduate Medical Centre, Karachi, from July 2013 to December 2013. 150 consecutive patients of Chronic Liver Disease diagnosed previously or newly diagnosed after admission, between the ages of 14 to 83 years, presenting with encephalopathy were enrolled in the study.
Data collection
A Performa was structured and check list was used for data collection. Detailed history was obtained with special consideration to fever, GI bleed, Burning micturition, Diarrhea, vomiting, constipation, abdominal pain and distension, jaundice, diet and drugs like sedatives, diuretics and cough syrups. Patients were examined with special attention to fever, anemia, jaundice, palmar erythema, spider nevi, gynaecomastia, asterixis, dehydration, edema, splenomegaly and ascites. Relevant hematological, biochemical and radiological investigations were ordered including complete blood count, urea, creatinine and electrolytes, liver function tests, coagulation profi le, serum proteins, serum albumin and globulin ratio, HBsAg, Anti HCV Antibody, urine D/R, ascitic fl uid D/R, serum ammonia, chest X-Ray, ultrasound abdomen, CT Brain and upper GI endoscopy. All patients underwent standard management during their hospital stay which included use of lactulose, metronidazole, 3rd generation cephalosporin, proton pump inhibitor, and vitamin K and FFP in patient with deranged coagulation profi le or GI bleed. Ryle's tube for feeding purposes was placed in patients with hepatic encephalopathy grade > 2. Outcomes assessed were the discharge or death during admission period.
Inclusion criteria
Cirrhosis was diagnosed on the basis of clinical signs & symptoms, laboratory fi ndings (deranged coagulation profi le and reversal of albumin/globulin ratio) and ultrasound fi ndings (size and echogenicity of liver, portal vein diameter, splenomegaly), and patients were categorized according to Child Pugh classifi cation ( Table 1) . Diagnosis of hepatic encephalopathy was made on the basis of history, physical examination and number connection test, and was graded from I to IV according to the West Haven criteria (Table 2) .
Exclusion criteria
Patients suffering from acute liver failure, non cirrhotic portal hypertension, intracranial lesions such as subdural Child A: 5-6, Child B: 7-9, Child C: [10] [11] [12] [13] [14] [15] hematoma, cerebral infarction or bleed, meningitis, encephalitis, brain abscess, hypoxia, hypercarbia, ketoacidosis, neuropsychiatric disorders or post-epileptic confusion were excluded from the study.
Operational defi nitions
Constipation was defined as failure to pass stool in 48 hours, infection as presence of fever, raised leukocyte count, significant pyuria (at greater than or equal to 10 leucocytes/mm3), >500 TLC or >250 neutrophils in ascitic D/R, electrolyte imbalance as high or low level of serum sodium or serum potassium as per the reference levels, upper gastrointestinal bleed as history of hematemesis or melena, dehydration as presence of dry tongue and loss of skin turgor, high protein diet as recent unrestricted high intake of proteins consumed in any form, renal impairment as creatinine of >2.
Data analysis
Statistical analysis was done using SPSS version 19 and the results were obtained in the terms of frequencies and percentages for descriptive analysis. Chi-Square and student t tests were used to analyze the numerical data and p value of <0.05 was considered statistically signifi cant.
RESULTS
A total number of one hundred and fi fty (n = 150) adults diagnosed cases of chronic liver disease who presented with hepatic encephalopathy irrespective of cause were included, out of them ninety six (n = 96, 64%) were females and fi fty four (n = 54, 36%) were males. Majority (n = 106, 70%) of the patients in our study belong from middle age group (i.e., 40-60 years of age), with mean age of 52.45 (±12.271) years. The age and gender distribution of the patients is shown in Figure 1 & 2.
The most common cause of chronic liver disease was found to be HCV in our patients. Frequency of viral hepatitis as a cause of chronic liver disease is mentioned in Figure 3 .
Out of 150 admitted patients, 107 (71.3%) were discharged, while 43 (28.7%) passed away. The frequency of grade of hepatic encephalopathy in our patients is shown in Figure 4 . Sign & symptoms (in the decreasing order of frequency) and the laboratory parameters of our patients are mentioned in the Figure 5 and More than one factor was found to be responsible in around 56% of patients while in 6.6% of cases none of these precipitating factors was isolated.
Grade of hepatic encephalopathy in our patients was directly related with the number of predisposing factors as shown in Table 5 . Grade -I Grade -II Grade -III Grade -IV
Figure 4: Classification of patients according to the grades of encephalopathy
To assess the severity of liver disease in our patients, Child-Pugh and MELD scoring systems were applied. The mean MELD score of our patients was 17.2 while mean Child-Pugh Score was 9.65.
Chi-square test was used to determine the relation of child's class with mortality rate, and it was found that mortality rate was signifi cantly high in child class C patients as shown in Tables 6.
The grade of hepatic encephalopathy at the time of presentation was directly related with the outcome (P value < 0.001) and is summarized in the Figure 6 .
DISCUSSION
A clearly defi ned precipitating factor is usually identifi ed in most patients with hepatic encephalopathy and the reversal or control of these factors is a key step in the management. The results of our study showed that 133 patients (88.66%) were suffering from Hepatitis C, and 11 patients (7.33%)
were of hepatitis B. Since it was a consecutive type of sampling, avoiding selection bias, so our fi ndings are in conformation with other studies, which also emphasize the fact that HCV is a rapidly growing problem and has already overtaken HBV in the etiogenesis of hepatic encephalopathy in Pakistan. 14, 15 A review article by Jafri described a rise in frequency of HCV as a cause of CLD in Pakistan from 16.67% in early nineties to 51-86% over a period of time. 16 Constipation was the commonest factor responsible for 53% cases of Hepatic encephalopathy in our patients, which is close to earlier published studies (as summarized in Table 7) , [17] [18] [19] [20] however contradictory with some of national and international reports. [21] [22] [23] [24] [25] [26] [27] [28] High frequency of constipation in our population was perhaps due to the fact that people of our country were probably less aware of the importance of constipation, precipitating hepatic encephalopathy. 19 Other factors responsible for prevalence of constipation among our setup include dietary restriction, poverty, lack of use or inappropriate dosing of lactulose due to fi nancial constrains, and lack of education regarding role of diet in chornic liver disease. 18, 20 Also most of the patient in our study belong middle age group, and that increasing age effects the bowel habits, it may partly be the reason of high prevalence of constipation in our study. 21, 22 Liver and brain biopsies were not taken in our study.
Proper guidance about a healthy diet which consists of plenty of fresh fruits and vegetable, foods high in fi ber content (including whole-meal bread, whole-wheat cereal and some raw bran in cereal or yoghurt), foods that are high in Omega-3 fatty acids and adequate fl uid intake to avoid dehydration should be provided to all the patients of Chronic liver disease. Exercise is an integral feature of Figure 6 : Grade of hepatic encephalopathy relating with outome in terms of mortality bowel management programs, and a lack of physical activity is a factor in the development of constipation in some people. Its effectiveness as an intervention to prevent or treat constipation, however, has yet to be demonstrated. 29 Lactulose is a commonly prescribed agent to relieve constipation in patients with chronic liver disease. It has an added advantage as a non-absorbable disaccharide inhibiting intestinal ammonia production by number of mechanisms. 30, 31 Infections like SBP, urinary tract infection and lower respiratory tract infection were the 2 nd most common factor present in 37% of cases corresponds to the study of Mohammad Tariq (2006) . 32 In West however the infection as a cause of hepatic encephalopathy is not very common, possibly due to more awareness and better nutrition status in their patients.
GI bleed was the third most important factor and was found in 34% of patients in our study, which is similar to 30% found in Mehboob F (2003) , 6 although lower than that reported by zakaria. 21 Electrolyte imbalance was found in 29% patients. Among electrolytes, hyponatremia was much more common than hypokalemia in our patients which was consistent with the fi ndings of Alam, 24 but contradicts with those ofAhmed.
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Electrolyte imbalances also correlate with the severity of the liver disease. 33 In our study, sedatives and Tranquilizers were not in use of any patient, and the history taken from the attendants and patients themselves were not suggestive of any self prescription of such drugs. In this study the majority of patients are in age group of 50 to 60 and the female were dominant, which is contradictory with the fi ndings observed in a retrospective study, of hepatic encephalopathy in Saudi Arabia 34 and in civil hospital Hyderabad. 13 When grading of encephalopathy is considered, in grade 3 and 4 electrolyte imbalance is the single most common precipitating factor involved.
The mortality rate of hepatic encephalopathy is high as shown by the study of Sargent et al 35 whereas, in our study the mortality was 29% and the majority were, Class C, Child-Pugh classifi cation. Patients with chronic HE are known to have better long term (5 years) survival than those who develop HE acutely (100% vs. 70% survival). 36 But this 
CONCLUSION
Constipation is the commonest cause of hepatic encephalopathy followed by infection, upper GI bleed and electrolyte imbalance. Control of constipation is very imperative in the avoidance of hepatic encephalopathy in our setup. The leading cause of constipation is a poor diet -poor choice of foods, or irregular eating. Patient counseling is a key competency element in its prevention. In most cases, simple changes in diet and lifestyle as described above can help relieve symptoms and manage constipation, and so very effectively prevent the development of this life threatening complication of cirrhosis.
